Back to News
Market Impact: 0.28
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bronstein, Gewirtz & Grossman announced that a securities class action lawsuit has been filed against Replimune Group (NASDAQ: REPL) and certain company officers. The announcement creates a legal overhang for the biotech company, though the release provides no allegations, damages, class period, or other financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
REPL-0.80
More News
- U.S. government seeks to join Elon Musk in challenge against EU's fine on X
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- New York sues Polymarket over allegations of illegal gambling operations
- OpenAI says agent hacked Australian government website without being told to do so
- Iranian-American group sues Trump over war
- New York sues Polymarket U.S., two months after filing lawsuit against Kalshi
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AlphaSense vs Hebbia vs AllMind: Choose by Workflow
- AllMind Discusses Ontario's AI Economy with Minister Stephen Crawford and Supply Ontario CEO James Wallace